Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neoscan Solutions is a German medical device company focused on magnetic resonance imaging systems, particularly compact point-of-care MRI for newborns and infants. Its lead commercial product is neo315, a 1.5 Tesla pediatric MRI system designed to bring radiation-free, high-resolution imaging closer to neonatal and pediatric care settings. The company emphasizes high-temperature superconductor magnet technology, cryogen-free operation, compact installation, and lower infrastructure requirements compared with conventional MRI systems. In addition to pediatric MRI, Neoscan Solutions is advancing superconducting magnet capabilities for research applications, including work related to an ultra-high-field 14T MRI system. The company collaborates closely with the Otto-von-Guericke University Magdeburg and the STIMULATE research campus.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neoscan Solutions.